The combined effect of drugs and tumor-specific antibodies in protection against a mouse lymphoma.
D000818:Animals; D000912:Antibodies, Neoplasm; D002699:Chlorambucil / Q000008:administration & dosage / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D007106:Immune Sera; D007167:Immunotherapy; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000276:immunology / Q000517:prevention & control; D011817:Rabbits / Q000276:immunology; D013997:Time Factors
D000912:Antibodies, Neoplasm; D007106:Immune Sera; D003561:Cytarabine; D002699:Chlorambucil; D008558:Melphalan